Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
Holding MDGL?
Track your performance easily

Madrigal Pharmaceuticals (MDGL) Income Statement

1,117 Followers

Madrigal Pharmaceuticals Income Statement

Last quarter (Q3 2024), Madrigal Pharmaceuticals's total revenue was $62.17M, an increase of Infinity% from the same quarter last year. In Q3, Madrigal Pharmaceuticals's net income was $-106.96M. See Madrigal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 76.81M---$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 76.81M-----
Operating Expense
$ 624.87M$ 380.50M$ 293.57M$ -242.48M$ 206.67M$ 94.97M
Operating Income
$ -548.05M$ -380.50M$ -293.57M$ -242.48M$ -206.67M$ -94.97M
Net Non Operating Interest Income Expense
$ 29.38M$ 6.87M$ -1.78M$ 363.00K$ 4.33M$ 11.02M
Other Income Expense
---$ -273.00K$ 100.00K-
Pretax Income
$ -518.67M$ -373.63M$ -295.35M$ -241.85M$ -202.24M$ -83.95M
Tax Provision
$ -16.25M$ -16.25M-$ -149.00K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -518.63M$ -373.63M$ -295.35M$ -241.85M$ -202.24M$ -83.95M
Basic EPS
$ -25.07$ -19.99$ -17.23$ -14.63$ -13.09$ -5.45
Diluted EPS
$ -25.07$ -19.99$ -17.23$ -14.63$ -13.09$ -5.45
Basic Average Shares
$ 82.93M$ 18.69M$ 17.14M$ 16.54M$ 15.45M$ 15.39M
Diluted Average Shares
$ 82.93M$ 18.69M$ 17.14M$ 16.54M$ 15.45M$ 15.39M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 390.51M$ 380.50M$ 293.57M$ -242.48M$ 206.67M$ 94.97M
Net Income From Continuing And Discontinued Operation
$ -518.63M$ -373.63M$ -295.40M$ -241.85M$ -202.24M$ -83.95M
Normalized Income
$ -402.41M-$ -233.33M-$ -202.24M$ -83.95M
Interest Expense
------
EBIT
$ -395.30M$ -360.92M$ -274.39M$ -241.85M$ -206.67M$ -94.97M
EBITDA
$ -392.96M$ -360.39M$ -273.12M$ -241.44M$ -206.20M$ -94.86M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis